Treatment success rate: previously treated TB cases in China
China: Treatment success rate: previously treated TB cases was 91 in 2023. ▼ Falling
Treatment success rate: previously treated TB cases in China, 1995–2023
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for treatment success rate: previously treated tb cases in China is 91, measured in 2023.
The figure is up 2.2% on the previous year and up 1.1% over ten years.
Over the whole period, treatment success rate: previously treated tb cases in China peaked at 95 in 1998 and was at its lowest, 81, in 2016.
That places China 24th out of 179 countries with data for 2023, putting it in the top quarter.
The long-run direction has been consistently falling across the 28 years of available data.
Treatment success rate: previously treated TB cases in China, year by year
| Year | Value | Change |
|---|---|---|
| 1995 | 92 | — |
| 1996 | 94 | +2.2% |
| 1998 | 95 | +1.1% |
| 1999 | 95 | +0.0% |
| 2000 | 89 | -6.3% |
| 2001 | 92 | +3.4% |
| 2002 | 88 | -4.3% |
| 2003 | 89 | +1.1% |
| 2004 | 89 | +0.0% |
| 2005 | 90 | +1.1% |
| 2006 | 89 | -1.1% |
| 2007 | 89 | +0.0% |
| 2008 | 90 | +1.1% |
| 2009 | 90 | +0.0% |
| 2010 | 90 | +0.0% |
| 2011 | 90 | +0.0% |
| 2012 | 90 | +0.0% |
| 2013 | 90 | +0.0% |
| 2014 | 88 | -2.2% |
| 2015 | 83 | -5.7% |
| 2016 | 81 | -2.4% |
| 2017 | 83 | +2.5% |
| 2018 | 81 | -2.4% |
| 2019 | 87 | +7.4% |
| 2020 | 89 | +2.3% |
| 2021 | 89 | +0.0% |
| 2022 | 89 | +0.0% |
| 2023 | 91 | +2.2% |
China compared with similar countries
- China's 91 is above the median for upper middle income countries, which is 63, 1.4× the median. (54 countries reporting)
- China's 91 is above the median for East Asia & Pacific, which is 73, 1.2× the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 94 | 92 | 95 | 4 |
| 2000s | 89.5 | 88 | 92 | 10 |
| 2010s | 86.3 | 81 | 90 | 10 |
| 2020s | 89.5 | 89 | 91 | 4 |
Countries ranked near China
More health data for China
- Un projection of annual infant deaths, annual growth rate -1.15 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0985 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,029 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,642 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 10 (2025)
- Population ages 00-04, female, annual growth rate -8.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0159 units per person (2025)
- Population ages 00-04, male, annual growth rate -8.73 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is treatment success rate: previously treated tb cases in China?
- Treatment success rate: previously treated tb cases in China was 91 in 2023, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate: previously treated tb cases recorded in China?
- The highest recorded value was 95 in 1998.
- What is the lowest treatment success rate: previously treated tb cases recorded in China?
- The lowest recorded value was 81 in 2016.
- How does China rank for treatment success rate: previously treated tb cases?
- China ranks 24th out of 179 countries with data for 2023.
- Is treatment success rate: previously treated tb cases rising or falling in China?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is falling.
- Where does this China data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: previously treated TB cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 28 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).